Schedule your GLP-1 consultation today and find out which medication is right for you
[37] On the other hand, an analysis of 9 studies that included mostly obese participants showed that people taking L-carnitine supplements lost an average of 2.9 more pounds than those who didnt
First, differences in design, individual characteristics, and follow-up duration among the included meta-analyses may contribute to heterogeneity in the results, particularly in the context of patients prior medication history
Beyond weight loss, GLP-1s are currently approved for additional uses for people who have obesity, including Wegovy for cardiovascular risk reduction, Zepbound for sleep apnea, and Ozempic for slowing chronic kidney disease in people with Type 2 diabetes
The two GLP-1R ligands were delivered i.p